Skip to main content
Caplight Logo









Gestalt Diagnostics

Gestalt Diagnostics

Private
Spokane, WashingtonHealthcare & Life Scienceshttps://gestaltdiagnostics.com/

Last Round

Series A

Apr 28, 2025

Total Funding Raised

$13.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Gestalt Diagnostics is a healthcare technology company that provides an AI-powered, cloud-based digital pathology platform to help pathologists diagnose diseases faster and more efficiently.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

digital pathologypathology workflowlaboratory information systemsLISmedical imagingpathology softwaredigital slide managementAI-enabled pathologypathology AIcloud-based pathologyvendor-neutral platformenterprise healthcare softwareremote pathologytelepathologyworkflow automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Gestalt Diagnostics Comparables

Compare Gestalt Diagnostics with similar companies based on industry and business-model similarity.

Gestalt Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Corista
87%
Proscia
87%
PathPresenter
84%

Gestalt Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 28, 2025
SeedMar 1, 2021

Gestalt Diagnostics Investors

Notable investors and investment history

Gestalt Diagnostics investors
InvestorRounds
Cowles VenturesSeed, Series A
Tacoma Venture FundSeed, Series A
KickstartSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 36% MoM.

  • May 19, 2026

    Grew 15% QoQ, from 33 to 38 employees.

Gestalt Diagnostics Filings

Explore SEC and related filing metadata, where available.

Gestalt Diagnostics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Gestalt Diagnostics's valuation, stock price, and market status.

Is Gestalt Diagnostics a public or private company?

Gestalt Diagnostics is a private company.

What is the current stock price of Gestalt Diagnostics?

Gestalt Diagnostics is a private company with no public stock price. No recent secondary market data is available.

How much is Gestalt Diagnostics worth (valuation)?

Valuation information for Gestalt Diagnostics is not publicly available.

Can I buy Gestalt Diagnostics stock?

Gestalt Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Gestalt Diagnostics's last funding round?

Gestalt Diagnostics's most recent funding round was Series A on April 28, 2025.

Who are the main investors in Gestalt Diagnostics?

Key investors in Gestalt Diagnostics include Cowles Ventures, Tacoma Venture Fund, Kickstart.

Will Gestalt Diagnostics IPO soon?

No public IPO plans have been announced for Gestalt Diagnostics.

How can I track Gestalt Diagnostics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Gestalt Diagnostics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSpokane, Washington
Employee Range15
Year Founded2017
Last FundingApr 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?